2018
Total knee arthroplasty in osteogenesis imperfecta
Brand J, Tyagi V, Rubin L. Total knee arthroplasty in osteogenesis imperfecta. Arthroplasty Today 2018, 5: 176-180. PMID: 31286040, PMCID: PMC6588802, DOI: 10.1016/j.artd.2018.09.006.Peer-Reviewed Original ResearchTotal knee arthroplastyKnee arthroplastyPrimary total knee arthroplastyOsteogenesis imperfectaMultiple clinical manifestationsAbnormal collagen formationSurgical treatmentClinical manifestationsSevere osteoarthritisPatient populationExtramedullary guideRare caseOrthopaedic surgeonsPatientsArthroplastyCollagen formationLife expectancyBone defectsImperfectaSpecial considerationGenetic diseasesFrequent basisOsteoarthritisAbnormalitiesDisease
2015
Total joint arthroplasty in patients with chronic infectious liver disease
Truntzer JN, Shah KN, Jenkins DR, Rubin LE. Total joint arthroplasty in patients with chronic infectious liver disease. Arthroplasty Today 2015, 2: 69-76. PMID: 28326402, PMCID: PMC4957173, DOI: 10.1016/j.artd.2015.07.001.Peer-Reviewed Original ResearchTotal joint arthroplastyInfectious liver diseasesLiver diseaseJoint arthroplastyExtrahepatic clinical manifestationsAppropriate patient selectionChronic hepatitis patientsGroup of patientsAsymptomatic patientsPerioperative optimizationHepatitis patientsSubclinical changesClinical presentationPatient selectionClinical manifestationsSuperior survivalPatientsInfection riskArthroplastyDiseaseWound healingImplant technologyContinued improvementImprovement of techniquesRelevant literature
2013
Management of the 'young' patient with hip disease.
Ritterman SA, Rubin LE. Management of the 'young' patient with hip disease. Rhode Island Medical Journal 2013, 96: 26-9. PMID: 23641435.Peer-Reviewed Original ResearchConceptsHip diseaseTotal hip replacementNative bone stockOlder patientsYounger patientsAvascular necrosisGeriatric patientsHip arthritisMetabolic causesSurgical techniqueRevision arthroplastyBone stockHip replacementPatientsYoung populationDiseasePopulationArthritisOsteoarthritisArthroplastySymptomsNecrosisCare
2005
Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors
Page C, Rubin LE, Gusberg RJ, Dardik A. Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors. Journal Of Vascular Surgery 2005, 42: 1014-1018. PMID: 16275464, DOI: 10.1016/j.jvs.2005.06.019.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAcute DiseaseAngiographyFactor VFactor V DeficiencyFibrinolytic AgentsFollow-Up StudiesHeparinHeterozygoteHumansHyperhomocysteinemiaInjections, Intra-ArterialMaleMiddle AgedMutationPeripheral Vascular DiseasesPopliteal ArteryThromboembolismThrombolytic TherapyTissue Plasminogen ActivatorConceptsPeripheral arterial diseaseArterial diseaseArterial thrombosisPre-existing peripheral arterial diseaseAcute popliteal artery thrombosisAcute arterial thrombosisPopliteal artery thrombosisIntra-arterial thrombolysisRisk factor modificationDeep venous thrombosisLong-term treatmentFactor V LeidenArtery thrombosisAcute thrombosisVenous thrombosisHomocysteine levelsFactor modificationV LeidenNormal limitsThrombosisHyperhomocysteinemiaFolic acidDiseaseDisordersAnticoagulation